Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 3:26 pm Purchase |
2023-12-31 | 13G | Actelis Networks, Inc. ASNS |
Armistice Capital, LLC | 301,490 9.990% |
301,490 (New Position) |
Filing History |
| 2024-02-14 3:25 pm Purchase |
2023-12-31 | 13G | American Rebel Holdings, Inc. AREB |
Armistice Capital, LLC | 1,938 7.420% |
1,938 (New Position) |
Filing History |
| 2024-02-14 3:24 pm Purchase |
2023-12-31 | 13G | Aquestive Therapeutics, Inc. AQST |
Armistice Capital, LLC | 3,924,000 5.880% |
3,924,000 (New Position) |
Filing History |
| 2024-02-14 3:24 pm Purchase |
2023-12-31 | 13G | Aptevo Therapeutics Inc. APVO |
Armistice Capital, LLC | 1,063 9.990% |
1,063 (New Position) |
Filing History |
| 2024-02-14 3:23 pm Purchase |
2023-12-31 | 13G | Aligos Therapeutics, Inc. ALGS |
Armistice Capital, LLC | 288,593 9.990% |
288,593 (New Position) |
Filing History |
| 2024-02-14 3:22 pm Purchase |
2023-12-31 | 13G | Adial Pharmaceuticals, Inc. ADIL |
Armistice Capital, LLC | 166,972 9.990% |
166,972 (New Position) |
Filing History |
| 2024-02-14 3:18 pm Unchanged |
2023-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY |
Armistice Capital, LLC | 976,000 2.730% |
0 (Unchanged) |
Filing History |
| 2024-02-14 3:07 pm Unchanged |
2023-11-30 | 13G | SuperCom Ltd. SPCB |
Armistice Capital, LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-14 3:03 pm Purchase |
2023-12-31 | 13G | XORTX Therapeutics Inc. XRTX |
Armistice Capital, LLC | 169,790 4.990% |
169,790 (New Position) |
Filing History |
| 2024-02-14 3:02 pm Purchase |
2023-12-31 | 13G | VivoPower International PLC VVPR |
Armistice Capital, LLC | 153,483 4.990% |
153,483 (New Position) |
Filing History |
| 2024-02-14 2:59 pm Purchase |
2023-12-31 | 13G | Top Ships Inc. TOPS |
Armistice Capital, LLC | 242,972 4.990% |
242,972 (New Position) |
Filing History |
| 2024-02-14 2:58 pm Purchase |
2023-12-31 | 13G | Talphera, Inc. TLPH |
Armistice Capital, LLC | 890,346 4.990% |
26,018 (+3.01%) |
Filing History |
| 2024-02-14 2:58 pm Purchase |
2023-12-31 | 13G | Tenax Therapeutics, Inc. TENX |
Armistice Capital, LLC | 17,241 0.070% |
17,241 (New Position) |
Filing History |
| 2024-02-14 2:57 pm Sale |
2023-12-31 | 13G | SURGALIGN HLDGS INC SRGAQ |
Armistice Capital, LLC | 482,321 4.990% |
-299,516 (-38.31%) |
Filing History |
| 2024-02-14 2:56 pm Purchase |
2023-12-31 | 13G | SenesTech, Inc. SNES |
Armistice Capital, LLC | 11,737 4.990% |
11,737 (New Position) |
Filing History |
| 2024-02-14 2:56 pm Sale |
2023-12-31 | 13G | scPharmaceuticals Inc. SCPH |
Armistice Capital, LLC | 0 0.000% |
-2,148,000 (Position Closed) |
Filing History |
| 2024-02-14 2:55 pm Purchase |
2023-12-31 | 13G | Arcadia Biosciences, Inc. RKDA |
Armistice Capital, LLC | 58,315 4.990% |
58,315 (New Position) |
Filing History |
| 2024-02-14 2:55 pm Sale |
2023-12-31 | 13G | Palatin Technologies, Inc. PTN |
Armistice Capital, LLC | 720,329 4.990% |
-334,877 (-31.74%) |
Filing History |
| 2024-02-14 2:54 pm Purchase |
2023-12-31 | 13G | Peraso Inc. PRSO |
Armistice Capital, LLC | 234,732 0.920% |
234,732 (New Position) |
Filing History |
| 2024-02-14 2:54 pm Purchase |
2023-12-31 | 13G | Palisade Bio, Inc. PALI |
Armistice Capital, LLC | 32,461 4.990% |
13,724 (+73.25%) |
Filing History |